The firm said the decision was taken because of a decline in demand for the vaccine.
AstraZeneca has begun the global withdrawal of its Covid-19 vaccine Vaxzevria, citing a surplus of updated vaccines.
AstraZeneca had recently admitted in court documents that its vaccine against Covid-19 has the potential to cause TTS, a rare ...
AstraZeneca said it was "incredibly proud" of the vaccine, but it had made a commercial decision. It said the rise of new coronavirus variants meant demand had shifted to the newer updated vaccines.
The firm's application to withdraw the vaccine was made on ... The Serum Institute of India (SII), which produced AstraZeneca's COVID-19 vaccine under the brand name Covishield, stopped ...
Drugmaker AstraZeneca is reportedly pulling its COVID-19 vaccine from global markets due to a surplus of updated alternatives ...
The company faced a class-action lawsuit that claimed the vaccine caused TTS – which stands for Thrombosis with ...
AstraZeneca has begun the worldwide withdrawal of its COVID vaccine - ending an era in which it saved millions of lives while being dogged by controversy. The jab, developed at Oxford University ...
AstraZeneca will withdraw its coronavirus vaccines, British media reported Wednesday. The decision by the British-Swedish pharmaceutical company came as a result of declining demand for the jab as ...
The Oxford-AstraZeneca Covid vaccine is being withdrawn worldwide ... The application to withdraw the vaccine was made on March 5 and came into effect on Tuesday. Similar applications will ...
AstraZeneca's Covid-19 vaccine is associated with another rare but fatal blood clotting disorder, according to new findings ...